Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
06/1999
06/16/1999CN1219881A Caprine arthritis-encephalitis virus provides immunoprotection against HIV-1 infection
06/15/1999US5911998 Inoculating cultures(which are free of adventitious microbial agents) with desired virus, then incubation and harvesting virus for use in vaccine
06/15/1999CA2014465C Herpesvirus recombinant poxvirus vaccine
06/10/1999WO1999016891B1 Methods of replicating virus in monocyte-derived macrophage cultures
06/10/1999WO1999015684A3 Expression of genes in hematopoietic stem cells in hischaemic conditions
06/10/1999WO1999013073A3 Viral vector system capable of expressing an apoptosis-associated gene
06/10/1999WO1999011764A3 Methods for generating high titer helper-free preparations of recombinant aav vectors
06/09/1999EP0920524A1 A short-shafted adenoviral fiber and its use
06/09/1999EP0920523A1 Hsv strain lacking functional icp27 and icp34.5 genes
06/09/1999EP0920491A1 Immortalized cell lines for virus growth
06/08/1999US5910434 Separately inserting minimal gag-pol and minimal env open reading frames into expression plasmids, inserting plasmids into eukaryotic cells, propagating, screening for the gene expression; gene therapy
06/08/1999US5910310 Genetic engineered antigenic material comprising isolated whole cell culture particles as a vaccine preventing viral diseases
06/03/1999WO1999027121A1 Development of viruses resistant to inactivation by the human complement system
06/03/1999WO1999009199A3 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor
06/02/1999EP0919627A2 Defective Adenoviruses and corresponding transcomplementant celllines
06/02/1999EP0919626A2 Defective Adenoviruses and corresponding transcomplementant celllines
06/02/1999EP0919625A2 Defective Adenoviruses and corresponding transcomplementant celllines
06/02/1999EP0919624A2 Defective Adenoviruses and corresponding transcomplementant celllines
06/02/1999EP0919241A1 Therapeutic agent, treatment method, prophylactic agent, and prophylactic method for canine and feline immunological diseases
06/02/1999EP0918875A1 Novel internal ribosome entry site and vector containing same
06/02/1999EP0918793A1 Inactivating process for lipid envelopped virus, and new antivirus lipopeptides
06/02/1999CN1218513A Vectors based on recombinant defenctive viral genmoes, and their use in formulation of vaccines
06/02/1999CN1218512A Recombinant adenoviral vectors for human tumour gene therapy
06/01/1999US5908923 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection
06/01/1999US5908785 Isolated baculovirus containing a polypeptide which suppresses melanization and encapsulation against lepidopteran insects and intensifies baculovirus infection of target insect; insecticides and biological pest control
06/01/1999US5908780 Cells transformed or transfected with HCMV US2 gene
06/01/1999US5908773 KSHV positive cell lines
05/1999
05/27/1999WO1999025861A2 Adenovirus vectors and method for reducing homologous recombination phenomena
05/27/1999WO1999025860A1 Vector for tissue-specific replication and gene expression
05/27/1999WO1999025851A1 VARIANT loxP SEQUENCES AND APPLICATION OF THE SAME
05/27/1999WO1999025377A1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection
05/27/1999WO1999025320A1 Targeted liposome gene delivery
05/27/1999CA2310563A1 Vector for tissue-specific replication and gene expression
05/26/1999EP0917592A1 Attenuated respiratory syncytial virus
05/26/1999CN1217632A Method of protein production using mitochondrial translation system
05/26/1999CN1217212A Vaccine both for hepatitis A and measles and production method therefor
05/25/1999US5906935 Cells transformed or transfected with HCMV US2-US5, US10-US11 genes
05/25/1999US5906821 Viral nucleotide sequences
05/25/1999CA1340565C Device and process for cell capture and recovery
05/20/1999WO1999024564A1 PRODUCTION OF NOVEL BOVINE RESPIRATORY SYNCYTIAL VIRUSES FROM cDNAs
05/20/1999WO1999024068A1 Immortal avian cell line to grow avian and animal viruses to produce vaccines
05/20/1999WO1999024054A1 Host derived proteins binding hcv: medical, diagnostic and purification use
05/20/1999CA2305715A1 Host derived proteins binding hcv: medical, diagnostic and purification use
05/19/1999EP0915648A1 Methods and compositions for the selective modification of nucleic acids
05/19/1999EP0434747B1 RECOMBINANT VACCINES BASED ON THE gB-PROTEIN OF MAREK'S DISEASE VIRUS
05/19/1999CN1217027A Parapoxviruses contg. foreign DNA, their prodn. and their use in vacciens
05/19/1999CN1216922A Porcine reproductive and respiratory syndrome vaccine
05/18/1999US5905040 Eukaryotic transfectants express self-assembled empty viral capsids which can be used to vaccinate against the virus or antigenically related species of the virus.
05/18/1999CA1340548C Method for producing native hiv gp160
05/14/1999WO1999023203A1 Immortalized, homozygous stat1-deficient mammalian cell lines and their uses
05/14/1999WO1999023107A1 Modification of virus tropism and host range by viral genome shuffling
05/14/1999WO1999022763A2 Encapsulated immunomodulators useful as vaccine adjuvants
05/14/1999WO1999011763A3 Method for purifying and concentrating aav-2 and antigen portions thereof
05/14/1999WO1999006068A3 Recombinant dimeric envelope vaccine against flaviviral infection
05/14/1999WO1997006272A3 High efficiency helper system for aav vector production
05/14/1999CA2309114A1 Immortalized, homozygous stat1-deficient mammalian cell lines and their uses
05/14/1999CA2307541A1 Encapsulated immunomodulators useful as vaccine adjuvants
05/12/1999EP0915165A1 Method for the helper virus-free packaging of a DNA-vector
05/12/1999EP0914460A1 Vehicle for the transport of molecular substances
05/12/1999EP0914458A1 Living recombinant avian vaccine, using as a vector the infectious avian laryngotracheitis virus
05/12/1999EP0914422A1 Mammalian genes involved in viral infection and tumor suppression
05/12/1999EP0914421A2 Hepatitis c virus ribozymes
05/12/1999EP0914140A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof
05/06/1999WO1999022001A1 Method for regulating the differentiation/proliferation of hematopoietic stem cells
05/06/1999WO1999021970A1 Insect immunoprotection and a pesticide
05/06/1999WO1999021969A1 Serum-free, low-protein media for rotavirus vaccine production
05/06/1999WO1999021886A1 PEPTIDES CAPABLE OF INHIBITING THE INTERACTION BETWEEN PRESENILINS AND THE β-AMYLOID PEPTIDE OR ITS PRECURSOR
05/06/1999WO1999021590A1 Gene therapy for stimulation of angiogenesis
05/06/1999WO1999015683A8 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
05/06/1999WO1999010516A3 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
05/06/1999EP0912744A1 Recombinant dna-vector comprising genomic equine arteritis virus sequences
05/06/1999EP0912724A1 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
05/06/1999EP0912188A1 Selective adsorbent for binding retroviruses
05/06/1999EP0541692B1 Herpes simplex virus vp16 vaccines
05/06/1999CA2307953A1 Gene therapy for stimulation of angiogenesis
05/06/1999CA2306564A1 Serum-free, low-protein media for rotavirus vaccine production
05/05/1999CN1215751A Analgesic health-care soap
04/1999
04/29/1999WO1999020779A1 Amplifiable adeno-associated virus (aav) packaging cassettes for the production of recombinant aav vectors
04/29/1999WO1999020778A1 Gene delivery vectors and their uses
04/29/1999WO1999020773A2 TRANSCRIPTIONALLY-ACTIVATED AAV INVERTED TERMINAL REPEATS (ITRs) FOR USE WITH RECOMBINANT AAV VECTORS
04/29/1999WO1999006069A9 Herpes virus replication defective mutants
04/29/1999CA2308008A1 Amplifiable adeno-associated virus (aav) packaging cassettes for the production of recombinant aav vectors
04/29/1999CA2306252A1 Gene delivery vectors and their uses
04/28/1999EP0910643A1 Ribonuclease resistant rna preparation and utilization
04/28/1999EP0910622A1 Medium for preserving biological materials
04/28/1999EP0910406A1 Recombinant canine herpesviruses
04/28/1999EP0910405A2 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection
04/28/1999EP0658119B1 New hiv-1 isolates of a subtype and its differential diagnosis, vaccine against hiv-1 infection of this subtype and process for preparing and using the hiv-1 isolate
04/27/1999CA2073168C Biomass for producing virus/virus antigen
04/22/1999WO1999019501A1 Non-integrating dna vector of retroviral origin having high-protein expression, and secreted immunogenic antigens
04/22/1999WO1999019464A1 Chromatographically concentrated baculovirus and methods
04/22/1999WO1999019345A1 Method for purifying retroviral particles and soluble viral antigens
04/22/1999WO1999018799A1 Treatment of neoplasms with viruses
04/22/1999WO1999004811A9 Artificial system for the production of infectious human papillomavirus
04/22/1999WO1999004011A3 Hiv-1 group o antigens and uses thereof
04/22/1999WO1998044788A9 Animal model for evaluation of vaccines
04/22/1999WO1998044143A9 Polymer-modified viruses
04/22/1999WO1998036779A3 System for the in vivo delivery and expression of heterologous genes in the bone marrow
04/22/1999WO1998008934A9 Serum-free mammalian cell culture medium, and uses thereof
04/22/1999CA2304375A1 Chromatographically concentrated baculovirus and methods
1 ... 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 ... 267